×

Register now for access to the Parexel Biotech Content Hub

First Name
Last Name
Company Name
Job Title
Country
Thank you!
Error - something went wrong!
   

Better Listening to Increase Site Engagement

November 15, 2017

Traditionally, the biopharmaceuticals industry has treated
feedback from clinical site investigator surveys as ancillary.
Parexel is out to change this, exploring and establishing
industry best practices for how to obtain insights from our
trial site partners that can be put into action. In fact, it is
difficult to overstate how vital our trial site partners are to
Parexel. Without them, we would not be able to develop
the new treatments that patients need. Clinical trials today
are more complex than ever, and systematically collecting
and analyzing investigator feedback gives CROs and our
industry the end-to-end data we need to add important
improvements to new trial designs from here forward. But
that’s just the beginning.

Previous Flipbook
Medical Writing Solutions
Medical Writing Solutions

Parexel's newly enhanced Medical Writing Solutions can help you optimize and better manage the development ...

Next Flipbook
Challenging Conventional Patient Recruitment And Care Strategies For Rare Disease Studies
Challenging Conventional Patient Recruitment And Care Strategies For Rare Disease Studies

Read this article to find out more about orphan diseases.